204 related articles for article (PubMed ID: 25291308)
1. Amendment to UK Patent Act provides further exception to patent infringement.
Sklan A
Pharm Pat Anal; 2014 Jul; 3(4):349. PubMed ID: 25291308
[No Abstract] [Full Text] [Related]
2. Will changes to patent infringements attract drug research in the UK?
Snodin M
Expert Opin Ther Pat; 2015; 25(9):949-51. PubMed ID: 25813963
[TBL] [Abstract][Full Text] [Related]
3. Patent watch: EPO rejects reach through claims.
Nat Rev Drug Discov; 2010 Jan; 9(1):12. PubMed ID: 20043023
[No Abstract] [Full Text] [Related]
4. The importance of patent sharing in neglected disease drug discovery.
Edlin C
Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
[No Abstract] [Full Text] [Related]
5. Amarin files patent infringement suit on lipid-lowering drug.
Sklan A
Pharm Pat Anal; 2014 Jul; 3(4):350. PubMed ID: 26900610
[No Abstract] [Full Text] [Related]
6. Is Canada patent deal obstructing Ebola vaccine development?
Attaran A; Nickerson JW
Lancet; 2014 Nov; 384(9958):e61. PubMed ID: 25467593
[No Abstract] [Full Text] [Related]
7. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
[No Abstract] [Full Text] [Related]
8. Patent-free pact pushes the boundaries of precompetitive research.
Dolgin E
Nat Med; 2014 Jun; 20(6):564-5. PubMed ID: 24901552
[No Abstract] [Full Text] [Related]
9. Research use exemptions to patent infringement for drug discovery and development in the United States.
Russo AA; Johnson J
Cold Spring Harb Perspect Med; 2014 Oct; 5(2):a020933. PubMed ID: 25359549
[TBL] [Abstract][Full Text] [Related]
10. Bilski blundering biotech.
Simmons WJ
Nat Biotechnol; 2009 Mar; 27(3):245-8. PubMed ID: 19270670
[No Abstract] [Full Text] [Related]
11. Patent-sharing scheme for neglected diseases may have catch.
Waters H
Nat Med; 2011 Dec; 17(12):1529. PubMed ID: 22146436
[No Abstract] [Full Text] [Related]
12. Safe harbors in Europe: an update on the research and Bolar exemptions to patent infringement.
Kupecz A; Roox K; Dekoninck C; Schertenleib D; Stief M; Sanna F; Orsingher M; Miralles S; Molina E; Crosse T; Gilbert M; James W
Nat Biotechnol; 2015 Jul; 33(7):710-5. PubMed ID: 26154008
[No Abstract] [Full Text] [Related]
13. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
Higgins MJ; Graham SJ
Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
[No Abstract] [Full Text] [Related]
14. Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney.
Melethil S
AAPS J; 2005 Oct; 7(3):E723-8. PubMed ID: 16353948
[TBL] [Abstract][Full Text] [Related]
15. Patent infringement.
Kempton L
Nat Rev Drug Discov; 2005 Feb; 4(2):97. PubMed ID: 15756754
[No Abstract] [Full Text] [Related]
16. Using market-exclusivity incentives to promote pharmaceutical innovation.
Kesselheim AS
N Engl J Med; 2010 Nov; 363(19):1855-62. PubMed ID: 21047231
[No Abstract] [Full Text] [Related]
17. High Court strikes down Merck's patent on alendronate.
Dyer O
BMJ; 2003 Feb; 326(7383):243. PubMed ID: 12560269
[No Abstract] [Full Text] [Related]
18. A cheat sheet to navigate the complex maze of exclusivities in the United States.
Peng B; Tomas MC
Pharm Pat Anal; 2014 Jul; 3(4):339-43. PubMed ID: 25291306
[No Abstract] [Full Text] [Related]
19. Hospira wins UK court case to overturn patents on Herceptin®.
Sklan A
Pharm Pat Anal; 2014 Jul; 3(4):350. PubMed ID: 26900609
[No Abstract] [Full Text] [Related]
20. First-to-invent versus first-to-file: impact of the AIA.
Rachinsky T; Sullivan C; Ghosh S; Resnick DS; Burton C; Armstrong M; Hanish JP; Sklan A
Pharm Pat Anal; 2014 Jul; 3(4):353-9. PubMed ID: 25291309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
